SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008249
Filing Date
2020-05-11
Accepted
2020-05-11 16:31:40
Documents
89
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 653270
2 ex31-1.htm EX-31.1 17183
3 ex31-2.htm EX-31.2 18043
4 ex32-1.htm EX-32.1 8633
  Complete submission text file 0001493152-20-008249.txt   5090324

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE hrow-20200331.xml EX-101.INS 818662
6 XBRL SCHEMA FILE hrow-20200331.xsd EX-101.SCH 75373
7 XBRL CALCULATION FILE hrow-20200331_cal.xml EX-101.CAL 86428
8 XBRL DEFINITION FILE hrow-20200331_def.xml EX-101.DEF 339592
9 XBRL LABEL FILE hrow-20200331_lab.xml EX-101.LAB 472991
10 XBRL PRESENTATION FILE hrow-20200331_pre.xml EX-101.PRE 393626
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 20865326
SIC: 2834 Pharmaceutical Preparations